Research collaboration

We are interested in being contacted regarding variants in KCNT2 in patients with a neurological phenotype, so that we can better understand the phenotypic and genotypic spectrum of this condition and better understand the underlying pathophysiology of the condition and possible targeted treatments. Please contact the co-moderators via this website or directly via email: elizabeth.palmer@health.nsw.gov.au or Rebecca.macintosh@health.nsw.gov.au